Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (681-690 of 895) with videos related to

Pageof 90
Sort By:
Leukemia & Lymphoma|August 29, 2015
Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European populationMaddalena Fratelli, Marco Bolis, Mami Kurosaki, et al.
Lancet (London, England)|July 25, 2018
Outrageous prices of orphan drugs: a call for collaborationLucio Luzzatto, Hanna I Hyry, Arrigo Schieppati, et al.
Journal of the American Society of Nephrology : JASN|October 11, 2017
Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic SyndromeElena Goicoechea de Jorge, Agustín Tortajada, Sheila Pinto García, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 10, 2017
Hemolytic Uremic Syndrome in Pregnancy and PostpartumAlexandra Bruel, David Kavanagh, Marina Noris, et al.
European Heart Journal|March 23, 2011
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trialsFrank A Holtkamp, Dick de Zeeuw, Pieter A de Graeff, et al.
Journal of Hypertension|March 2, 2006
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyHermann Haller, Gian C Viberti, Albert Mimran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2011
Embryonic stem cells, derived either after in vitro fertilization or nuclear transfer, prolong survival of semiallogeneic heart transplantsBarbara Imberti, Federica Casiraghi, Daniela Cugini, et al.
The Journal of Clinical Investigation|April 28, 2026
Anti-nephrin antibodies are not enriched in patients with primary and post-transplant recurrent podocytopathiesFrancesco Pecoraro, Luca Perico, Federica Casiraghi, et al.
Journal of the American Society of Nephrology : JASN|February 1, 2008
The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndromeRuben Martinez-Barricarte, Gaia Pianetti, Ruxandra Gautard, et al.
Frontiers in Medicine|May 9, 2022
A Home-Treatment Algorithm Based on Anti-inflammatory Drugs to Prevent Hospitalization of Patients With Early COVID-19: A Matched-Cohort Study (COVER 2)Elena Consolaro, Fredy Suter, Nadia Rubis, et al.
Pageof 90

Showing results (681-690 of 895) with videos related to

Sort By:
Pageof 90
Leukemia & Lymphoma|August 29, 2015
Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European populationMaddalena Fratelli, Marco Bolis, Mami Kurosaki, et al.
Lancet (London, England)|July 25, 2018
Outrageous prices of orphan drugs: a call for collaborationLucio Luzzatto, Hanna I Hyry, Arrigo Schieppati, et al.
Journal of the American Society of Nephrology : JASN|October 11, 2017
Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic SyndromeElena Goicoechea de Jorge, Agustín Tortajada, Sheila Pinto García, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 10, 2017
Hemolytic Uremic Syndrome in Pregnancy and PostpartumAlexandra Bruel, David Kavanagh, Marina Noris, et al.
European Heart Journal|March 23, 2011
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trialsFrank A Holtkamp, Dick de Zeeuw, Pieter A de Graeff, et al.
Journal of Hypertension|March 2, 2006
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyHermann Haller, Gian C Viberti, Albert Mimran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2011
Embryonic stem cells, derived either after in vitro fertilization or nuclear transfer, prolong survival of semiallogeneic heart transplantsBarbara Imberti, Federica Casiraghi, Daniela Cugini, et al.
The Journal of Clinical Investigation|April 28, 2026
Anti-nephrin antibodies are not enriched in patients with primary and post-transplant recurrent podocytopathiesFrancesco Pecoraro, Luca Perico, Federica Casiraghi, et al.
Journal of the American Society of Nephrology : JASN|February 1, 2008
The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndromeRuben Martinez-Barricarte, Gaia Pianetti, Ruxandra Gautard, et al.
Frontiers in Medicine|May 9, 2022
A Home-Treatment Algorithm Based on Anti-inflammatory Drugs to Prevent Hospitalization of Patients With Early COVID-19: A Matched-Cohort Study (COVER 2)Elena Consolaro, Fredy Suter, Nadia Rubis, et al.
Pageof 90